06/19/2026
Could drugs like Ozempic do more than treat diabetes and support weight loss?
In this research project, Sam Kwon, a third-year medical student at GW, explores whether GLP-1 receptor agonists can improve recovery after kidney cancer surgery.
Analyzing data from nearly 10,000 patients, the study found that those taking GLP-1 medications had fewer complications, fewer hospital readmissions, and even lived nearly two years longer.
This work highlights an exciting possibility in cancer care: using medications we already have in new ways to improve patient outcomes.